Compare UFPI & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UFPI | BLCO |
|---|---|---|
| Founded | 1955 | 1853 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Forest Products | Ophthalmic Goods |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 6.0B |
| IPO Year | 2011 | 2022 |
| Metric | UFPI | BLCO |
|---|---|---|
| Price | $95.13 | $16.33 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 12 |
| Target Price | ★ $102.50 | $18.45 |
| AVG Volume (30 Days) | 358.1K | ★ 407.5K |
| Earning Date | 04-29-2026 | 04-29-2026 |
| Dividend Yield | ★ 1.47% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.00 | N/A |
| Revenue | $3,941,182,000.00 | ★ $5,101,000,000.00 |
| Revenue This Year | $2.04 | $8.63 |
| Revenue Next Year | $5.61 | $5.58 |
| P/E Ratio | $19.10 | ★ N/A |
| Revenue Growth | ★ 21.62 | 6.47 |
| 52 Week Low | $84.82 | $10.45 |
| 52 Week High | $118.00 | $18.92 |
| Indicator | UFPI | BLCO |
|---|---|---|
| Relative Strength Index (RSI) | 55.43 | 50.21 |
| Support Level | $88.09 | $16.35 |
| Resistance Level | $107.70 | $16.81 |
| Average True Range (ATR) | 2.32 | 0.45 |
| MACD | 1.17 | 0.11 |
| Stochastic Oscillator | 89.07 | 74.30 |
UFP Industries Inc is a supplier of lumber to the manufactured housing industry. Today UFP Industries is a multibillion-dollar holding company with subsidiaries around the globe that serve three markets: retail, packaging and construction. Its business segments consist of UFP Retail Solutions, UFP Packaging, UFP Construction, All other and Corporate. It describes itself as an innovation company, a logistics company, a design company, an engineering and value-added product and solutions company.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.